Form 4: Health Catalyst Executive Linda Llewelyn Sells Shares Under 10b5-1 Trading Plan

Linda Llewelyn, Chief People Officer of Health Catalyst, Inc., sold 1,324 shares of common stock at a price of $8.16 per share on October 15, 2024, under a pre-arranged trading plan.

Summary

• On October 17, 2024, a Form 4 filing with the SEC reported that Linda Llewelyn, Chief People Officer of Health Catalyst, Inc. (HCAT), sold 1,324 shares of common stock.
• The transaction occurred on October 15, 2024, at a price of $8.16 per share.
• Following the sale, Llewelyn directly owns 114,275 shares of Health Catalyst common stock.
• The sale was executed under a pre-arranged trading plan adopted on March 12, 2024, in accordance with Rule 10b5-1.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

Insider sales are a common occurrence, and sales under 10b5-1 plans are generally viewed as less impactful since they are pre-scheduled. However, investors often monitor insider transactions for signals about a company's prospects.

Stakeholder Impact

• The sale of shares by an executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the sale relative to the executive's holdings.

Key Dates